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Abstract. Synthesis of H1˚ histone protein, in the developing 
rat brain, seems to be regulated mainly at the post-transcrip-
tional level. Since regulation of RNA metabolism depends on 
a series of RNA-binding proteins, we have been searching for 
RNA-binding proteins involved in the post-transcriptional 
regulation of the H1˚ gene. We recently reported isolation, 
from a cDNA expression library, of an insert encoding a novel 
protein, the C-terminal half of which is identical to that of 
PEP-19, a brain-specific protein involved in calcium metabo-
lism. The novel protein was called long PEP-19 isoform (LPI). 
Herein we show that LPI, as well as PEP-19, can bind H1˚ 
RNA. Moreover, in order to improve production of functional 
LPI/PEP-19, we modified the protocol normally adopted for 
preparing histidine tagged-proteins from bacteria, by adding 
an additional purification step. We also found that both LPI 
and PEP can compete for H1˚ RNA binding with PIPPin 
(CSD-C2), another RNA-binding protein previously discov-
ered in our laboratory. Since PEP19/LPI contain a calmodulin 
binding domain, we finally investigated whether their ability 
to bind RNA is affected by calmodulin. Our results show 
that calmodulin interferes with binding of H1˚ RNA to both 
PEP-19 and LPI, while it is not able to bind RNA on its own. 
This finding suggests that calcium/calmodulin may have a role 
in controlling H1˚ mRNA metabolism in the developing brain.
Introduction
Eukaryotic DNA is packaged in a highly organized protein 
complex called chromatin, the smallest unit of which is the 
nucleosome. Nucleosomes are formed by about 200 base pairs 
of DNA wrapped around a protein core, consisting of two 
molecules each of the histones H2A, H2B, H3 and H4. A fifth 
histone, the linker histone H1, binds DNA where it enters and 
leaves the nucleosome. Nucleosomes also provide cells with a 
system able to regulate gene expression, since their positioning 
on different parts of the gene with different functional proper-
ties can both activate or repress transcription (1). Nucleosomes 
can be remodeled by different mechanisms, one of which 
involves incorporation of specific histone variants (also called 
replacement histones) (2).
In the mammalian brain, regulation of stability, localiza-
tion and translation of a number of transcripts plays a key role 
in the establishment and maintenance of nerve cell functions 
(3-5). Among post-transcriptionally regulated genes, those 
encoding histone variants, such as H1˚ (6-8) and H3.3 (2,9,10) 
are of interest for the possible involvement of histone variants 
in the replication-independent chromatin remodelling induced 
by extracellular stimuli (2). In looking for proteins able to bind 
mRNAs encoding the histone variants H1˚ and H3.3, we iden-
tified a set of proteins that bind the one and/or the other histone 
mRNAs (11). We also cloned a cDNA that encodes a protein, 
that we called PIPPin (12-14), now also known as CSD-C2, 
that contains a cold shock domain and binds both mRNAs at 
the level of the polyadenylation signal (13).
More recently, we isolated a second novel cDNA (15), 
encoding a putative protein of 94 amino acids, the C-terminal 
half (41 amino acids) of which is identical to that of PEP-19, a 
brain-specific protein of 62 amino acids, involved in calcium 
metabolism and calmodulin binding (16-18). The novel protein, 
that we called long PEP-19 isoform (LPI), is rat brain-specific 
and is likely derived by alternative splicing from the same 
gene as PEP-19 (15).
In order to clarify whether LPI actually is an RNA-binding 
protein, as suggested by the original isolation of the corre-
sponding cDNA from an expression library by direct binding 
to RNA, we produced recombinant 6 histidine-tagged LPI and 
PEP-19. Production in bacteria of histidine-tagged proteins 
is, however, hampered by the fact that more than 90% of the 
foreign protein is recovered as unfolded, inactive form, in 
inclusion bodies (19). Here we report the results obtained by 
using, in the binding assays, LPI/PEP-19 prepared according 
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to the standard protocol, normally used to purify histidine-
tagged proteins, to which we added a further purification step, 
that allows a better yield of active protein.
Materials and methods
Animals and research ethics. Sprague-Dawley rats (Stefano 
Morini, San Polo d'Enza, Italy) were housed in our institutional 
animal care facility under direction of a licensed veterinary. 
Procedures involving animals were conducted according to 
the European Community Council Directive 2010/63/EU, 
reducing to a minimum the use of animals.
Preparation of recombinant LPI and PEP-19 proteins, 
containing N-terminal tags of 6 histidines. Cloning of the 
cDNAs encoding LPI (EMBL ID: AJ493658) and PEP-19 
(EMBL ID: M24852), and production of the N-terminal 6 
histidine-tagged LPI and PEP-19 proteins, have been previ-
ously described (15). Recombinant PIPPin, used as a control, 
was prepared as previously described (20).
Chromatographic purification of recombinant LPI/PEP-19. 
Recombinant PIPPin, LPI and PEP-19 were purified from the 
insoluble fraction of bacterial homogenate by metal-affinity 
chromatography on a selective nickel-nitriloacetic (Ni-NTA)-
conjugated agarose matrix (QIAexpress System, Qiagen), 
according to the manufacturer's instructions. At this aim, 
the bacterial pellet, which contained the insoluble inclusion 
bodies, was resuspended in 50 mM Tris-HCl, pH 7.2; 50 mM 
NaCl, 8 M urea and incubated for 5 min at 80˚C, in order to 
allow protein solubilization. Proteins were allowed to refold 
during chromatography, by sequentially washing the column 
with buffers containing decreasing amounts of urea (from 8 
to 0 M). Finally, bound proteins were eluted with 300 mM 
imidazole. Specific activity of the recombinant protein was 
highly improved by gel filtration of the imidazole-eluted 
protein through an equal volume of G-100 Sephadex in 50 mM 
Tris-HCl (pH 7.2) (patent N˚ PA2009A000029).
Preparation of in vitro transcripts and T1 RNase protection 
assay. 32P-radiolabeled H1˚ RNA was prepared as previously 
described (11), using as a template the plasmid pMH1˚ (21), 
which contains the H1˚ insert (EMBL ID: X70685). About 
0.5x106 cpm (0.5-2.0x107 cpm/pmol of RNA) of purified H1˚ 
RNA were mixed with recombinant protein (50 ng), prepared 
as described above. For the T1 protection assay, we used a 
previously described method (11) except that cross-linking 
of RNA to proteins was performed before incubation with T1 
RNase (EC 3.1.27.3; Roche). RNA-protein complexes were 
analyzed by denaturing electrophoresis on sodium dodecyl 
sulfate (SDS)-polyacrylamide slab gel (PAGE). At the end of 
the run, the gel was directly exposed to X-ray film for autoradi-
ography. The gels were also stained with Coomassie Brilliant 
Blue R-250 (Sigma), to confirm loading of equal amounts of 
proteins per lane.
Competition experiments aimed at analyzing RNA-binding 
specificity were performed in the presence of 2:1 or 5:1 excess of 
unlabeled RNA. Competition experiments aimed at analyzing 
interference effects of LPI or PEP-19 on PIPPin (CSD-C2) 
binding to H1˚ RNA were performed in the presence of 1:1 or 
4:1 excess of the competing protein. Competition experiments 
aimed at analyzing interference effects of calmodulin on LPI 
and PEP19 binding to H1˚ RNA were performed in the pres-
ence of 1:1 or 4:1 excess of calmodulin. As a control of the 
interference experiments we used bovine serum albumin at the 
same concentration as calmodulin.
Figure 1. LPI and PEP-19 bind H1˚ RNA. (A) 6His-tagged LPI or (B) PEP-19 
(50 ng each) were incubated with 0.5x106 cpm of radiolabeled H1˚RNA. 
Competition experiments were performed in the presence of excess unlabeled 
H1˚ RNA (2:1), H3.3 RNA (2:1) or Cox IV RNA (5:1). At the end of the T1 
RNase protection assay, RNA-protein covalent complexes were analyzed by 
SDS-PAGE and the gels were exposed to X-ray films for 16 h. Representative 
films showing the RNA-protein complexes obtained in the absence (-) or in the 
presence of competing RNA are shown in the upper part of A and B. The lower 
parts of A and B are graphical representations of the statistical analysis of at 
least three independent experiments. Grey bars indicate mean values for each 
condition. SDs are also indicated (black bars).
Figure 2. LPI and PEP-19 bind H3.3 RNA. LPI (lane 1), PEP-19 (lane 2) or 
PIPPin (lane 3, PIP) (50 ng each) was incubated with 0.5x106 cpm radiolabeled 
H3.3 RNA. At the end of the T1 RNase protection assay, the RNA-protein 
covalent complexes were analyzed as described in Materials and methods and 
in Fig. 1 legend.
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Results
RNA-binding activity of PEP-19 and LPI and specificity of 
RNA-binding. One possible way to identify RNA-binding 
proteins is to screen expression libraries with 32P-labeled RNA 
of interest. As reported elsewhere (15), we recently described a 
cDNA, isolated through such a screening and encoding a trans-
lational product that we called LPI, since it was found to be a 
rat-specific, alternative splicing variant of the already known 
PEP-19 peptide. The two proteins share the C-terminal half, 
which includes a calmodulin-binding domain. Recombinant 
LPI, as well as PEP-19 and PIPPin (CSD-C2), all from rat, were 
expressed in E. coli and purified from the insoluble fraction of 
the bacterial homogenate by chromatography. To confirm that 
LPI can bind H1˚ RNA, as suggested by the approach used 
to identify it, and to investigate PEP-19 binding properties, 
T1 RNase assays were performed, using in vitro transcribed 
H1˚ RNA and 50 ng of each protein. Both LPI (Fig. 1A) and 
PEP-19 (Fig. 1B) were able to bind rat H1˚ RNA, each forming 
a major complex which migrates with an apparent molecular 
weight of 14 and 12 kDa, respectively. In addition, to ascertain 
that the binding of LPI and PEP-19 to H1˚ RNA was specific, 
T1 RNase protection assays were performed in the presence of 
excess unlabeled RNAs. Unlabeled H1˚ RNA competed with 
his labeled counterpart in the binding reactions with both LPI 
(Fig. 1A) and PEP-19 (Fig. 1B). Unlabeled H3.3 RNA (Fig. 1) 
also competed with H1˚ RNA binding, suggesting an interac-
tion of both proteins with both RNAs. In contrast, the 3'UTR 
of Cox IV RNA (Fig. 1) was unable to compete. Fig. 1 also 
shows a graphical representation of the statistical analysis of at 
least three independent experiments, for both proteins.
The ability of LPI and PEP-19 to bind H3.3 RNA was 
confirmed by direct T1 RNase protection assay (Fig. 2). Both 
LPI (lane 1) and PEP-19 (lane 2) strongly bound H3.3 RNA, 
suggesting an interaction of these proteins with both the H1˚ 
and H3.3 histone variants RNAs. Fig. 2 also shows H3.3 RNA 
binding to PIPPin, the RNA-binding activity of which has 
been previously reported (12,13).
PEP-19 and LPI compete with PIPPin for H1˚ RNA-binding. 
Since both LPI and PEP-19 are able to bind the H1˚ RNA, 
we assessed their ability to compete with PIPPin for binding. 
Fig. 3 shows the results of these analyses: when used in equi-
molar amounts, LPI and PIPPin form roughly similar amounts 
of complexes. On the other hand, PEP-19 seems to bind H1˚ 
RNA more strongly than PIPPin.
Effect of calmodulin on PEP and LPI binding to H1˚ RNA. 
Since both LPI and PEP are able to bind H1˚ RNA, we reasoned 
that the site involved in RNA binding might be in their common 
Figure 4. Calmodulin interferes with RNA binding to PEP-19 and LPI but does not bind RNA. (A) LPI or (B) PEP-19 (50 ng each) were incubated with radio-
labeled H1˚RNA. Competition experiments were performed in the presence of 1:1 or 4:1 excess of calmodulin (CaM), or 4:1 excess of bovine serum albumin 
(BSA). At the end of the T1 RNase protection assay, RNA-protein covalent complexes were analyzed as described in the legend to Fig. 1. Representative 
films are shown in the upper part of A and B. The lower parts of A and B are graphical representations of the statistical analysis of at least three independent 
experiments. Grey bars indicate mean values for each condition. SDs are also indicated (black bars).
Figure 3. PEP-19 and LPI compete with PIPPin for H1˚ RNA binding. PIPPin 
(PIP) (50 ng) were incubated with 0.5x106 cpm of radiolabeled H1˚RNA. 
Competition experiments were performed in the presence of a 1:1 or 1:4 excess 
of LPI or PEP-19 (PEP).
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C-terminal half. This part of both molecules also contains 
the calmodulin-binding site. We therefore, asked whether 
calmodulin can interfere with RNA binding. Calmodulin was 
able to reduce the binding of both proteins to RNA (Fig. 4). 
The interfering effect of calmodulin is specific, since the same 
amount of BSA did not compete. Graphical representation of 
the statistical analysis of at least three independent experiments 
are shown in Fig. 4, for both proteins.
The effect of calmodulin is not due to a putative ability 
to bind RNA: this protein, like BSA, was unable to form 
complexes with H1˚ RNA on its own (Fig. 4).
Discussion
Post-transcriptional regulation of RNA fate depends on the 
association with different sets of proteins (RNA-binding 
proteins, RBPs), which often contain different RNA-binding 
domains as well as additional domains involved in protein-
protein interactions (22). The RNA-RBP association can be 
modulated by environmental cues, both during development 
and in differentiated cells (5,23).
During mammalian brain maturation, several classes of 
neurons accumulate both H3.3, a core histone (9,10), and H1 ,˚ 
a linker histone (7,10). The concentration of the corresponding 
mRNAs decreases between embryonal Day 18 (E18) and 
postnatal Day 10 (P10), with an inverse correlation to the 
accumulation of the corresponding proteins. The observed 
differences are not due to modifications of gene transcription 
(24) and should depend on post-transcriptional regulation. The 
search of RBPs able to bind H1˚- and/or H3.3-mRNA, and 
possibly involved in their metabolism, in the past led to the 
identification of three H1˚ RNA-binding proteins (p40, p70 
and p110) (11) and to cloning of an H3.3/H1˚ RNA-binding 
protein (PIPPin, also known as CSD-C2), which contain 
a cold-shock domain (13). More recently, a second protein 
has been cloned through an experimental approach based 
on screening of an expression cDNA library by a functional 
binding assay with a labeled, in vitro transcribed histone 
RNA (15). The novel cDNA corresponds to a splicing variant 
of the mRNA encoding PEP-19, an already known peptide 
which contains, in its C-terminal half, IQ motifs able to bind 
calmodulin. The new protein, that we called LPI, shares 
with PEP-19 the calmodulin-binding C-terminal half. The 
present study was therefore aimed, first of all, at investigating 
whether LPI and PEP-19 interact with H1˚ RNA. The analysis 
required preparation of recombinant PEP-19 and LPI, but, 
when produced in bacteria as 6 histidine-tagged, most of 
these proteins were in the inclusion bodies. It was therefore 
necessary to set an experimental procedure that, moving from 
the standard denaturation/refold protocols, could allow a high 
yield of functional protein. In particular, according to stan-
dard protocols, proteins are finally dialyzed. During this step, 
however, most protein aggregated and precipitated. We found 
that replacement of the final dialysis with a filtration through 
an equal volume of G-100 Sephadex could restore solubility 
of the proteins. Moreover, solubility is maintained even after 
repeated freeze-thaw cycles.
LPI and PEP-19 prepared through this procedure, like the 
previously identified PIPPin protein, are able to bind both H1˚ 
and H3.3 RNAs. The fact that all three proteins, which are also 
able to compete for binding to RNA, recognize both histone 
variant RNAs suggest the existence of a common regula-
tion of the synthesis of replacement histones. Once we had 
demonstrated that both LPI and PEP-19 are able to bind H1˚ 
and H3.3 RNAs, we assessed the possible interfering effect 
of calmodulin on RNA-binding. The finding that calmodulin 
actually reduces binding of RNA to both proteins sheds light 
on the putative signals which could regulate expression of 
histone variants in the brain. Calcium-dependent signals are 
indeed of particular importance in the nervous system, and 
deregulated increases in intracellular ionized calcium can 
result in neuronal damage and death. Many of the effects of 
calcium are mediated by calmodulin, and the brain contains 
tissue-specific peptides (such as PEP-19, neurogranin and 
neuromodulin) which seem to act as calmodulin antagonists 
(17). Moreover, it has been recently suggested that PEP-19 is a 
critical determinant of synaptic plasticity (25). Our discovery 
that PEP-19 and LPI bind H1˚ histone mRNA and that this 
binding is affected by calmodulin suggests that, in the brain, 
post-transcriptional regulation of H1˚ histone synthesis may be 
regulated by calcium signals, and perhaps by neuronal activity.
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